In addition, compared to the ovaries of PCOS mice, ovaries from INF39 (an NLRP3-specific inhibitor)-treated mice displayed more preantral and antral follicles and corpus luteum but fewer atypical follicles. This evidence concerns the gene NLRP3 and polycystic ovary syndrome.